Pancreatic Cancer

  • RTOG 0848 (SOMC Pending)- Phase III Trial Evaluating both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma (Arm 2 Closed to Accrual)
  • ECOG E2211- Phase II Randomized Study of Temozolomide or Temozolomide and Cepecitabine in Patients with Advanced Pancreatic Neuroendocrine Tumors